Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. 1988

L Y Chak, and P S Gill, and A M Levine, and P R Meyer, and J A Anselmo, and Z Petrovich
Department of Radiation Oncology, University of Southern California School of Medicine, Los Angeles 90033.

Twenty-four patients with acquired immunodeficiency syndrome (AIDS) received 80 courses of radiation therapy for Kaposi's sarcoma (KS). Pain and other symptoms due to mass effects were well controlled, but KS lesions often persisted in irradiated sites. Acute radiation toxicity to doses of approximately 2,000 cGy in ten fractions to the oral cavity and/or the foot were significant and may limit the dose and the efficacy of radiotherapy in patients with the epidemic form of KS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012514 Sarcoma, Kaposi A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. Kaposi Sarcoma,Kaposi's Sarcoma,Multiple Idiopathic Pigmented Hemangiosarcoma,Kaposis Sarcoma,Sarcoma, Kaposi's

Related Publications

L Y Chak, and P S Gill, and A M Levine, and P R Meyer, and J A Anselmo, and Z Petrovich
September 1995, Mayo Clinic proceedings,
L Y Chak, and P S Gill, and A M Levine, and P R Meyer, and J A Anselmo, and Z Petrovich
August 1991, The Journal of urology,
L Y Chak, and P S Gill, and A M Levine, and P R Meyer, and J A Anselmo, and Z Petrovich
October 1992, Archives of ophthalmology (Chicago, Ill. : 1960),
L Y Chak, and P S Gill, and A M Levine, and P R Meyer, and J A Anselmo, and Z Petrovich
September 1985, Annals of internal medicine,
L Y Chak, and P S Gill, and A M Levine, and P R Meyer, and J A Anselmo, and Z Petrovich
September 1995, American journal of obstetrics and gynecology,
L Y Chak, and P S Gill, and A M Levine, and P R Meyer, and J A Anselmo, and Z Petrovich
February 1985, Journal of the Royal Society of Medicine,
L Y Chak, and P S Gill, and A M Levine, and P R Meyer, and J A Anselmo, and Z Petrovich
February 1984, The Ohio State medical journal,
L Y Chak, and P S Gill, and A M Levine, and P R Meyer, and J A Anselmo, and Z Petrovich
July 1989, The American journal of medicine,
L Y Chak, and P S Gill, and A M Levine, and P R Meyer, and J A Anselmo, and Z Petrovich
September 2008, The Journal of laryngology and otology,
L Y Chak, and P S Gill, and A M Levine, and P R Meyer, and J A Anselmo, and Z Petrovich
January 2000, European journal of ophthalmology,
Copied contents to your clipboard!